Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancy
Pavlos Missios, … , David T. Ting, George Q. Daley
Pavlos Missios, … , David T. Ting, George Q. Daley
Published November 15, 2021
Citation Information: J Clin Invest. 2021;131(22):e145142. https://doi.org/10.1172/JCI145142.
View: Text | PDF
Research Article Oncology

LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancy

  • Text
  • PDF
Abstract

High expression of LIN28B is associated with aggressive malignancy and poor survival. Here, probing MYCN-amplified neuroblastoma as a model system, we showed that LIN28B expression was associated with enhanced cell migration in vitro and invasive and metastatic behavior in murine xenografts. Sequence analysis of the polyribosome fraction of LIN28B-expressing neuroblastoma cells revealed let-7–independent enrichment of transcripts encoding components of the translational and ribosomal apparatus and depletion of transcripts of neuronal developmental programs. We further observed that LIN28B utilizes both its cold shock and zinc finger RNA binding domains to preferentially interact with MYCN-induced transcripts of the ribosomal complex, enhancing their translation. These data demonstrated that LIN28B couples the MYCN-driven transcriptional program to enhanced ribosomal translation, thereby implicating LIN28B as a posttranscriptional driver of the metastatic phenotype.

Authors

Pavlos Missios, Edroaldo Lummertz da Rocha, Daniel S. Pearson, Julia Philipp, Maria M. Aleman, Mehdi Pirouz, Dorian Farache, Joseph W. Franses, Caroline Kubaczka, Kaloyan M. Tsanov, Deepak K. Jha, Brian Pepe-Mooney, John T. Powers, Richard I. Gregory, Amy S.Y. Lee, Daniel Dominguez, David T. Ting, George Q. Daley

×

Figure 6

LIN28B cooperates with MYCN to alter ribosomal dynamics.

Options: View larger image (or click on image) Download as PowerPoint
LIN28B cooperates with MYCN to alter ribosomal dynamics.
(A) Venn diagra...
(A) Venn diagrams of LIN28B-bound (gray) and transcripts with significant differential polysome enrichment (blue and red) as well as LIN28B-bound and transcriptional targets of MYCN (yellow). (B) Gene ontology analysis (GO Biological Process 2018) of indicated overlaps (LIN28B-bound and polysome-enriched transcripts [left] and LIN28B-bound and MYCN targets [right]). (C) Scatterplot depicting transcripts depending on their polysome enrichment and LIN28B binding. MYCN targets of the ribosome are indicated in red. (D) Protein synthesis analysis measured by metabolic labeling using S35-labeled methionine in the respective groups (n = 6 biological replicates per group). (E) In vitro translation assay with RPS29-reporter mRNA on lysates of BE2C-KO cells expressing the different LIN28B proteins: WT and deficient in RNA binding (MUT), only intact zinc knuckle domain (ZKD), and only intact cold shock domain (CSD) (n = 3 biological replicates). Differential comparisons were made between BE2C CTRL and BE2C LIN28B-KO cells. MYCN targets were defined using CHIPseeker (promoter ≤1kb). Statistical data in D were assessed using 2-tailed Student’s t test, in E using 1-way ANOVA with Tukey’s multiple-comparison test; data are presented as mean ± SEM. *P < 0.05; ****P < 0.0001. GO analysis in B was performed with Enrichr. MYCN CHIP-Seq data were derived from Durbin et al. (74).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts